Forte Biosciences Inc (FBRX)
Forte Biosciences Inc (FBRX) is a NASDAQ-listed biotechnology company. Forte Biosciences Inc common stock is the security described here, and the supplied security context is common equity, indicating an ownership interest in the company rather than a fund, note, or depositary receipt. The company is associated with research and development activity in the healthcare sector, with a focus on biotechnology and work related to immune-mediated conditions. This overview describes the listed shares only and does not imply investment characteristics or operating results. Investors typically use this kind of listing information to identify the issuer, exchange, sector, and instrument type.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-FBRX
|
$30.71
|
-40.0% Downside
|
Overvalued
|
$66.60
|
30.1% Upside
|
Undervalued
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
-16.5x
|
29.8x
|
—
|
1.16 B
|
1.194 B
|
0.0%
|
77.1%
|
19.6
|
—
|
78.3%
|
